Indeed, we found that PIN1 inhibition in breast cancer xenografted mice sensitized tumors cells to paclitaxel treatment, not only by reducing the tumor mass but also by preventing the enrichment of the CSC population, a mechanism known to spur tumor recurrence after therapy (17). Here, PIN1 is linked to breast carcinoma.